Personal information

Verified email domains

organoids, antivrals, resporatory viruses
Belgium

Activities

Employment (2)

SGS (Belgium): Mechelen, Vlaanderen, BE

2023-06-06 to present | Clinical Data Manager (Biometrics)
Employment
Source: Self-asserted source
Thuc Nguyen Dan Do

Katholieke Universiteit Leuven: Leuven, Vlaanderen, BE

2019-09-01 to 2023-05-31 | Research Associate (Department of Microbiology, Immunology and Transplantation)
Employment
Source: Self-asserted source
Thuc Nguyen Dan Do

Education and qualifications (3)

KU Leuven: Leuven, Vlaanderen, BE

2019-09-01 to present | Ph.D. in Biomedical Sciences (Department of Microbiology, Immunology, and Transplantation)
Education
Source: Self-asserted source
Thuc Nguyen Dan Do

Radboud Universiteit: Nijmegen, Gelderland, NL

2017-09-01 to 2019-08-31 | M.Sc. in Biomedical Sciences (Faculty of Medical Sciences)
Education
Source: Self-asserted source
Thuc Nguyen Dan Do

Ho Chi Minh City University of Medicine and Pharmacy: Ho Chi Minh City, VN

2009-09-01 to 2014-10-05 | B.Pharm. (Faculty of Pharmacy)
Education
Source: Self-asserted source
Thuc Nguyen Dan Do

Professional activities (2)

Jagiellonian University: Krakow, PL

2022-04-03 to 2022-06-30 | Visiting Scholar (Malopolska Centre of Biotechnology )
Invited position
Source: Self-asserted source
Thuc Nguyen Dan Do

Epithelix Sarl: Geneva, CH

2021-07-01 to 2021-08-31 | Visiting Researcher (R&D department)
Invited position
Source: Self-asserted source
Thuc Nguyen Dan Do

Funding (1)

Organovir for Virus Research - An innovative training - ITN programme

2019-09 to 2022-09 | Grant
EU Research Executive Agency (Leuven, BE)
Part of GRANT_NUMBER:

812673

Source: Self-asserted source
Thuc Nguyen Dan Do

Works (12)

The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model

Antiviral Research
2024-11 | Journal article
Contributors: Thuc Nguyen Dan Do; Rana Abdelnabi; Bernadett Boda; Samuel Constant; Johan Neyts; Dirk Jochmans
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model.

bioRxiv
2024-05-15 | Other
SOURCE-WORK-ID:

4160602

Contributors: Thuc Nguyen Dan Do; rana abdelnabi; Bernadett Boda; Samuel Constant; Johan NEYTS; DIRK JOCHMANS
Source: check_circle
KU Leuven
grade
Preferred source (of 2)‎

Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411

Antiviral Research
2023-11 | Journal article
Contributors: Robert Konkel; Aleksandra Milewska; Nguyen Dan Thuc Do; Emilia Barreto Duran; Artur Szczepanski; Jacek Plewka; Ewa Wieczerzak; Sofia Iliakopoulou; Triantafyllos Kaloudis; Dirk Jochmans et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients

2022-11-10 | Journal article
Contributors: Thuc Nguyen Dan Do
Source: Self-asserted source
Thuc Nguyen Dan Do

SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells

Viruses-Basel
2022-05-02 | Journal article
SOURCE-WORK-ID:

3748408

Part of ISSN: 1999-4915
WOSUID:

WOS:000803167400001

Contributors: Thuc Nguyen Dan Do; Sandra Claes; Dominique Schols; Johan NEYTS; DIRK JOCHMANS
Source: check_circle
KU Leuven
grade
Preferred source (of 3)‎

Terbinafine resistance explains treatment failure in a patient with tinea corporis

Nederlands Tijdschrift voor Geneeskunde
2021-11-30 | Journal article
SOURCE-WORK-ID:

3725309

Part of ISSN: 1569-013X
Contributors: Jochem Buil B; Bronckers Inge M G J; Driessen Rieke J B; Thuc Nguyen Dan Do; Melchers Willem J G; Verweij Paul E
Source: check_circle
KU Leuven
grade
Preferred source (of 2)‎

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

eBioMedicine
2021-10 | Journal article
Contributors: Rana Abdelnabi; Caroline S. Foo; Suzanne J.F. Kaptein; Xin Zhang; Thuc Nguyen Dan Do; Lana Langendries; Laura Vangeel; Judith Breuer; Juanita Pang; Rachel Williams et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues

Antiviral Research
2021-09 | Journal article
Contributors: Leentje Persoons; Evelien Vanderlinden; Laura Vangeel; Xinyu Wang; Nguyen Dan Thuc Do; Shi-Yan Caroline Foo; Pieter Leyssen; Johan Neyts; Dirk Jochmans; Dominique Schols et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

Antiviral Research
2021-08 | Journal article
SOURCE-WORK-ID:

3476691

Part of ISSN: 0166-3542
WOSUID:

WOS:000672095900002

Contributors: Nguyen Dan Do Thuc; Kim Donckers; Laura Vangeel; Arnab K Chatterjee; Philippe A Gallay; Michael D Bobardt; John P Bilello; Tomas Cihlar; Steven De Jonghe; Johan NEYTS et al.
Source: check_circle
KU Leuven
grade
Preferred source (of 2)‎

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

2021-03-25 | Preprint
Contributors: Thuc Nguyen Dan Do; Kim Donckers; Laura Vangeel; Arnab K. Chatterjee; Philippe A. Gallay; Michael D. Bobardt; John P. Bilello; Tomas Cihlar; Steven De Jonghe; Johan Neyts et al.
Source: check_circle
Crossref

Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial

Ebiomedicine
2021-03-19 | Journal article
SOURCE-WORK-ID:

3420387

Part of ISSN: 2352-3964
WOSUID:

WOS:000647447600003

Contributors: Laurens Liesenborghs; Isabel Spriet; DIRK JOCHMANS; Ann Belmans; Iwein Gyselinck; Laure-Anne Teuwen; Sebastiaan ter Horst; Erwin Dreesen; Tatjana Geukens; M. M. Engelen et al.
Source: check_circle
KU Leuven
grade
Preferred source (of 2)‎

Clinical cure rate and cost-effectiveness of carbapenem-sparing beta-lactams vs. meropenem for Gram-negative infections: A systematic review, meta-analysis, and cost-effectiveness analysis.

International Journal Of Antimicrobial Agents
2019-12 | Journal article
SOURCE-WORK-ID:

2839848

Part of ISSN: 0924-8579
WOSUID:

WOS:000498867900017

Contributors: Chi Phuong Nguyen; Thuc Nguyen Dan Do; Roger Bruggemann; Jaap Ten Oever; Eva Kolwijck; Eddy M M Adang; Heiman F L Wertheim
Source: check_circle
KU Leuven
grade
Preferred source (of 2)‎